PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2013 | 69 | 03 |

Tytuł artykułu

Rodokokoza jako zoonoza

Warianty tytułu

EN
Rhodococcosis as a zoonosis

Języki publikacji

PL

Abstrakty

EN
Rhodococcosis is known largely as an infectious disease of young foals that causes losses in the horse breeding industry. Besides in animals, the infection can also be a significant diagnostic, clinical and therapeutic problem in human medicine. The aim of the paper is to present the zoonotic aspect of rhodococcosis, including basic data about pathogen, epidemiology, pathogenesis, clinical picture, pathology, diagnosis and therapy of the disease. R. equi was isolated for the first time in 1923 by Magnusson in Sweden from a dead foal with the signs of pyogranulomatous pneumonia. The first case of human R. equi infection has been described in 1967 in a 29-year-old man subjected to immunosuppressive therapy. Hundreds of new cases of human rhodococcosis have been described since that time all over the world. The majority of human cases of R. equi infections concern patients immunodeppressed during the course of different diseases or treated with immunosuppressive drugs. However, 10-15% of cases concern fully immunocompetent patients. The role of farm animals as a primary source of infection to people has not been proved, but the importance of a contaminated environment seems to be evident. Molecular studies of human R. equi strains revealed that only 21% of isolates contained the typical for foal strains VapA plasmid. This suggests that the pathogenesis of the disease in humans may be different from that described in animals. Immunological investigations supporting the role of cell-mediated immunity in R. equi infections explain why AIDS patients with confirmed CD4+ lymphocytes deficiency and decreasing ability of INF gamma synthesis are more susceptible to infection in comparison to immunocompetent people. The clinical course of rhodococcosis in humans is varied, but in 80% of cases the process is localized in the respiratory tract. The mortality rate in immunosuppressed patients ranges between 20-55%. Diagnosis of rhodococcosis in humans is based on the isolation and identification of the pathogen in antemortem collected biological material. Radiology and CT may also be helpful. Myc. tuberculosis and Nocardia spp. infections should be included as a differential diagnosis. Treatment of rhodococcosis in humans, similarly to animals, usually requires a several-week course of a combination of 2-3 antibiotics. In practice intravenous application of vancomycin, carbapenem or aminoglycosides combined with oral administration of azithromycin and/or rifampin is used. In apparently cured individuals relapses occur frequently in which pathological changes are localized in primarily involved or in other tissues and organs.

Wydawca

-

Rocznik

Tom

69

Numer

03

Opis fizyczny

s.139-144,bibliogr.

Twórcy

  • Katedra Epizootiologii i Klinika Chorób Zakaźnych, Wydział Medycyny Weterynaryjnej, Uniwersytet Przyrodniczy w Lublinie, ul.Głęboka 30, 20-612 Lublin
autor
  • Katedra Epizootiologii i Klinika Chorób Zakaźnych, Wydział Medycyny Weterynaryjnej, Uniwersytet Przyrodniczy w Lublinie, ul.Głęboka 30, 20-612 Lublin
autor
  • Katedra Epizootiologii i Klinika Chorób Zakaźnych, Wydział Medycyny Weterynaryjnej, Uniwersytet Przyrodniczy w Lublinie, ul.Głęboka 30, 20-612 Lublin
autor
  • Katedra Epizootiologii i Klinika Chorób Zakaźnych, Wydział Medycyny Weterynaryjnej, Uniwersytet Przyrodniczy w Lublinie, ul.Głęboka 30, 20-612 Lublin

Bibliografia

  • 1.Arlotti M., Zoboli G., Moscatelli G. L., Magnani G., Maserati R., Borghi V., Andreoni M., Libanore M., Bonazzi L., Piscina A., Ciammarughi R.: Rhodococcus equi infection in HIV-positive subjects: a retrospective analysis of 24 cases. Scand. J. Infect. Dis. 1996, 28, 463-467.
  • 2.Behnes C. L., Neumann S., Schweyer S., Radzun H. J.: Pleural malakoplakia caused by Rhodoccocus equi infection in a patient after stem cell transplantation. Diagn. Pathol. 2012, 23, 7-20.
  • 3.Bell K. S., Philp J. C., Aw D. W., Christofi N.: The genus Rhodococcus. J. Appl. Microbiol. 1998, 85, 195-210.
  • 4.Bowersock T. L., Salmon S. A., Portis E. S., Prescott J. F., Robison D. A., Ford C. W., Watts J. L.: MICs of oxazolidinones for Rhodococcus equi strains isolated from humans and animals. Antimicrob. Agents Chemother. 2000, 44, 1367-1369.
  • 5.Carman M. G., Hodges R. T.: Distribution of Rhodococcus equi in animals, birds and from the environment. N. Z. Vet. J. 1987, 35, 114-115.
  • 6.Chow K. M., Szeto C. C., Chow V. C., Wong T. Y., Li P. K.: Rhodococcus equi peritonitis in continuous ambulatory peritoneal dialysis. J. Nephrol. 2003, 16, 736-739.
  • 7.Cornish N., Washington J. A.: Rhodococcus equi infections: clinical features and laboratory diagnosis. Curr. Clin. Top Infect. Dis. 1999, 19, 198-215.
  • 8.Donisi A., Suardi M. G., Casari S., Longo M., Cadeo G. P., Carosi G.: Rhodococcus equi infection in HIV-infected patients. AIDS 1996, 10, 359-362.
  • 9.Etta L. L. van, Filice G. A., Ferguson R. M., Gerding D. N.: Corynebacterium equi: a review of 12 cases of human infection. Rev. Infect. Dis. 1983, 5, 1012-1018.
  • 10.Giguere S., Hondalus M. K., Yager J. A., Darrah P., Mosser D. M., Prescott J. F.: Role of the 85-kilobase plasmid and plasmid encoded virulence-associated protein A in intracellular survival and virulence of Rhodococcus equi. Infect. Immun. 1999, 67, 3548-3557.
  • 11.Giguère S., Lee E. A., Guldbech K. M., Berghaus L. J.: In vitro synergy, pharmacodynamics, and postantibiotic effect of 11 antimicrobial agents against Rhodococcus equi. Vet. Microbiol. 2012, 160, 207-213.
  • 12.Giguere S., Prescott J. F.: Clinical manifestations, diagnosis, treatment, and prevention of Rhodococcus equi infections in foals. Vet. Microbiol. 1997, 56, 313-334.
  • 13.Golub B., Falk G., Spink W. W.: Lung abscess due to Corynebacterium equi: report of first human infection. Ann. Intern. Med. 1967, 66, 1174-1177.
  • 14.Grądzki Z., Ziętek-Barszcz A.: Detection of Rhodococcus equi in tracheobronchial aspirate of foals in enzootic farms depending on age and season. Bull. Vet. Inst. Pulawy 2011, 55, 619-624.
  • 15.Harvey R. L., Sunstrum J. C.: Rhodococcus equi infection in patients with and without human immunodeficiency virus infection. Rev. Infect. Dis. 1991, 13, 139-145.
  • 16.Kamboj M., Kalra A., Kak V.: Rhodococcus equi brain abscess in a patient without HIV. J. Clin. Pathol. 2005, 58, 423-425.
  • 17.Kanaly S. T., Hines S. A., Palmer G. H.: Failure of pulmonary clearance of Rhodococcus equi infection in CD4+ T-lymphocyte-deficient transgenic mice. Infect. Immun. 1993, 61, 4929-4932.
  • 18.Kedlaya I., Ing M. B., Wong S. S.: Rhodococcus equi infections in immunocompetent hosts: case report and review. Clin. Infect. Dis. 2001, 32, E39-46.
  • 19.Lasky J. A., Pulkingham N., Powers M. A., Durack D. T.: Rhodococcus equi causing human pulmonary infection: review of 29 cases. South Med. J. 1991, 84, 1217-1220.
  • 20.Linares M. J., López-Encuentra A., Perea S.: Chronic pneumonia caused by Rhodococcus equi in a patient without impaired immunity. Eur. Respir. J. 1997, 10, 248-250.
  • 21.Magnusson H.: Spezifische infektiose pneumonie beim fohlen: ein neuer eitererreger beim pferd. Arch. Wiss. Prakt. Tierheilkd. 1923, 50, 22-38.
  • 22.Makrai L., Fodor L., Csivincsik A., Varga J., Senoner Z., Szabó B.: Characterisation of Rhodococcus equi strains isolated from foals and from immunocompromised human patients. Acta Vet. Hung. 2000, 48, 253-259.
  • 23.Meijer W. G., Prescott J. F.: Rhodococcus equi. Vet. Res. 2004, 35, 383-396.
  • 24.Mosser D. M., Hondalus M. K.: Rhodococcus equi: an emerging opportunistic pathogen. Trends Microbiol. 1996, 4, 29-33.
  • 25.Munoz P., Palomo J., Guinea J., Yanez J., Giannella M., Bouza E.: Relapsing Rhodococcus equi infection in a heart transplant recipient successfully treated with long-term linezolid. Diagn. Microbiol. Infect. Dis. 2008, 60, 197-199.
  • 26.Muntaner L., Leyes M., Payeras A., Herrera M., Gutierrez A.: Radiologic features of Rhodococcus equi pneumonia in AIDS. Eur. J. Radiol. 1997, 24, 66-70.
  • 27.Nordmann P., Ronco E., Guenounou M.: Involvement of interferon-γ and tumor necrosis factor-α in host defense against Rhodococcus equi. J. Infect. Dis. 1993, 167, 1456-1459.
  • 28.Nordmann P., Ronco E., Nauciel C.: Role of T-lymphocyte subsets in Rhodococcus equi infection. Infect. Immun. 1992, 60, 2748-2752.
  • 29.Nordmann P., Rouveix E., Guenounou M., Nicolas M. H.: Pulmonary abscess due to a rifampin and fluoroquinolone resistant Rhodococcus equi strain in a HIV infected patient. Eur. J. Clin. Microbiol. Infect. Dis. 1992, 11, 557-558.
  • 30.Prescott J. F.: Rhodococcus equi: an animal and human pathogen. Clin. Microbiol. Rev. 1991, 4, 20-34.
  • 31.Rasmussen T. T., Kirkeby L. P., Poulsen K., Reinholdt J., Kilian M.: Resident aerobic microbiota of the adult human nasal cavity. APMIS 2000, 108, 663-675.
  • 32.Ribeiro M. G., Takai S., Vargas A. C. de, Mattos-Guaraldi A. L., Ferreira Camello T. C., Ohno R., Okano H., Silva A. V.: Short report: Identification of virulence-associated plasmids in Rhodococcus equi in humans with and without acquired immunodeficiency syndrome in Brazil. Am. J. Trop. Med. Hyg. 2011, 85, 510-513.
  • 33.Roda R. H., Young M., Timpone J., Rosen J.: Rhodococcus equi pulmonary-central nervous system syndrome: brain abscess in a patient on high-dose steroids - a case report and review of the literature. Diagn. Microbiol. Infect. Dis. 2009, 63, 96-99.
  • 34.Silva P., Miyata M., Sato D. N., Santos A. C., Mendes N. H., Leite C. Q.: Rhodococcus equi isolation from sputum of patients with suspected tuberculosis. Mem. Inst. Oswaldo Cruz. 2010, 105, 199-202.
  • 35.Scott M. A., Graham B. S., Verrall R., Dixon R., Schaffner W., Tham K. T.: Rhodococcus equi - an increasingly recognized opportunistic pathogen. Report of 12 cases and review of 65 cases in the literarure. Am. J. Clin. Pathol. 1995, 103, 649-655.
  • 36.Scotton P. G., Tonon E., Giobbia M., Gallucci M., Rigoli R., Vaglia A.: Rhodococcus equi nosocomial meningitis cured by levofloxacin and shunt removal. Clin. Infect. Dis. 2000, 30, 223-224.
  • 37.Strunk T., Gardiner K., Simmer K., Atlas D., Keil A. D.: Rhodococcus equi meningitis after ventriculoperitoneal shunt insertion in a preterm infant. Pediatr. Infect. Dis. J. 2007, 26, 1076-1077.
  • 38.Takai S.: Epidemiology of Rhodococcus equi infections: a review. Vet. Microbiol. 1997, 56, 167-176.
  • 39.Takai S., Ohbushi S., Koike K., Tsubaki S., Oishi H., Kamada M.: Prevalence of virulent Rhodococcus equi in isolates from soil and feces of horses from horse-breeding farms with and without endemic infections. J. Clin. Microbiol. 1991, 29, 2887-2889.
  • 40.Takai S., Sasaki Y., Ikeda T., Uchida Y., Tsubaki S., Sekizaki T.: Virulence of Rhodococcus equi isolates from patients with and without AIDS. J. Clin. Microbiol. 1994, 32, 457-460.
  • 41.Thomsen F., Henriques R., Magnusson M.: Corynebacterium equi Magnusson isolated from a tuberculoid lesion in a child with adenitis coli. Dan. Med. Bull. 1968, 15, 135-138.
  • 42.Toyooka K., Takai S., Kirikae T.: Rhodococcus equi can survive a phagolysosomal environment in macrophages by suppressing acidification of the phagolysosome. J. Med. Microbiol. 2005, 54, 1007-1015.
  • 43.Verville T. D., Huycke M. M., Green?eld R. A., Fine D. P., Kuhls T. L., Slater L. N.: Rhodococcus equi infections of humans. 12 cases and a review of the literature. Medicine (Baltimore) 1994, 73, 119-132.
  • 44.Weinstock D. M., Brown A. E.: Rhodococcus equi: an emerging pathogen. Clin. Infect. Dis. 2002, 34, 1379-1385.
  • 45.Yamshchikov A. V., Schuetz A., Lyon G. M.: Rhodococcus equi infection. Lancet Infect. Dis. 2010, 10, 350-359.
  • 46.Ziętek-Barszcz A., Grądzki Z.: Optimisation of the DNA-extraction method from foal faeces for the diagnosis of Rhodococcus equi infections using PCR. Bull. Vet. Inst. Pulawy 2009, 53, 345-349.
  • 47.Zink M. C., Yager J. A., Prescott J. F., Fernando M. A.: Electron microscopic investigation of intracellular events after ingestion of Rhodococcus equi by foal alveolar macrophages. Vet. Microbiol. 1987, 14, 295-305.
  • 48.Zink M. C., Yager J. A., Prescott J. F., Wilkie B. N.: In vitro phagocytosis and killing of Corynebacterium equi by alveolar macrophages of foals. Am. J. Vet. Res. 1985, 46, 2171-2174.
  • 49.Zopf W.: Uber Ausscheidung von Fettfarbstoffen (Lipochromen) seitens gewisser Spaltpilze. Ber. Dtsch. Bot. Ges. 1891, 9, 22-28.

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-51959f35-7d5d-4711-8c60-7f735618e2c9
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.